GovChime
AWARDBPA CALLOther than small business

BPA call 75F40122F19002DELOITTE CONSULTING LLP

Overview

Award facts

Net obligations
$10.85M
$10,851,085of $10.85M potential value
Outlays (paid to date)
$10.85M
$10.85M paid of $10.85M obligated$10,851,085
Period of performance
Mar 31, 2022 to Aug 31, 2024
Ended
Modifications
6
Latest action Apr 10, 2025
Contract type
BPA call
PIID 75F40122F19002

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

CDER EVENT DATA MANAGEMENT (EDM 7.0)

Dates and value

Award date
Signed on Mar 31, 2022
Potential end of performance
Aug 30, 2024
Current value
$10,851,085Base and exercised options
Potential value (if all options are exercised)
$10,851,085
Parent contract vehicle
75F40122A00001 (BPA, multiple award) — 15 orders recorded under it

Obligations by fiscal year of action

  • FY2025: -$50,733 (de-obligation)
  • FY2024: $2,681,872
  • FY2023: $3,622,477
  • FY2022: $4,597,469

Total across 4 fiscal years: $10,851,085

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Apr 10, 2025. View on USAspending · Recipient on SAM.gov

Recipient

NameDELOITTE CONSULTING LLP
LocationARLINGTON, VA
UEICKV2L9GZKJK3
CAGE code1TTG5
Business sizeOther than small businessSize at award, per the contracting officer
Organization typePartnership
Parent companyDELOITTE CONSULTING LLP

Business types and certifications

For-profit organizationPartnership or LLP

As represented in SAM.gov at the time of the action.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. Food And Drug Administration
  3. FDA OFFICE OF ACQ GRANT SVCS
Funded by
  1. Department of Health and Human Services
  2. Food And Drug Administration
  3. FDA OFFICE OF ACQ GRANT SVCS
Funded from
Human drugs; Coronavirus emergency funding supplemental; Fda user fees (non general fund)Program activities075-0600Federal accounts (agency financial reports)

Place of performance

Place of performance
Silver Spring, Montgomery County, Maryland 20993-0002
Congressional district (place of performance)
MD-08As reported at the time of the action

Classification and competition

Classification

NAICS
541512COMPUTER SYSTEMS DESIGN SERVICES
Product or service (PSC)
R699SUPPORT- ADMINISTRATIVE: OTHER (service)

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Subject to multiple award fair opportunityMAFO
Set-aside
Not reported
Contract pricing
Labor hoursZ
Offers received
1

Contract details

Service Contract Act labor standards
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Performance-based service acquisition
No - service where PBA is not used.N

Transaction history

Modification history

Base award
Mar 31, 2022Base obligation at award: $3,122,489
Latest action
Apr 10, 2025 — CloseoutModification P00006; obligation change -$50,733; administrative: no change in scope or value
Latest substantive action
Jan 31, 2024 — Supplemental agreement (within scope)Modification P00004; obligation change +$1,779,988
Latest funding action
Nov 20, 2023 — Funding onlyModification P00003; obligation change +$600,000; funding only: changes obligations, not scope
Actions by type
  • Base award1
  • Supplemental agreement (within scope)2
  • Funding only1
  • Option exercised1
  • Closeout1
  • Other administrative action1
7 actions recorded, Mar 31, 2022 to Apr 10, 2025; each action counted once.

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$50,733
Latest action: change in base and all options
-$50,733

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
Yes

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
BPA callA
Parent vehicle type
BPAE
Parent vehicle: multiple or single award
Multiple awardM
Parent vehicle agency
Food And Drug Administration7524
Awarding agency code
7500
Awarding sub-tier code
7524
Contracting office code
75F401
Transactions recorded under this award key
7

Funding

Funding agency code
7500
Funding sub-tier code
7524
Funding office code
75F401
Treasury accounts
  • 075-2022/2022-0600-000
  • 075-2023/2023-0600-000
  • 075-2024/2024-0600-000
  • 075-X-0600-000
Object classes
  • 25.2: Other services from non-Federal sources
  • 25.3: Other goods and services from Federal sources
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
  • V: Non-emergency P.L. 117-2
COVID-19 supplemental obligations
$985,670
COVID-19 supplemental outlays
$985,670